Xeris Pharmaceuticals | XERS - Interest Income



Xeris Pharmaceuticals reported $948K in Interest Income for its fiscal quarter ending in June of 2025.


Interest Income Change Date
Celltrion KRW 7.53B 1.21B Mar/2025
Dianthus Therapeutics USD 3.4M 587K Jun/2025
Eli Lilly USD 40M 8.3M Jun/2025
Kangmei Pharma 4.31M 8.34M Sep/2024
Knight Therapeutics CAD 2.46M 498K Sep/2024
Laboratorios Farma 139K 42K Jun/2025
Medical Developments International 174K 31K Dec/2024
Pacira USD 5.01M 1.89M Jun/2025
Pharma Mar 4.8M 6.4M Dec/2024
Qiagen NV USD 13.86M 1.53M Jun/2025
Sartorius 54.9M 77.1M Mar/2025
Supernus Pharmaceuticals USD 4.53M 103K Jun/2025
Tilray USD 12.83M 20.19M May/2024
Zhangzhou Pientzehuang Pharmaceutical 2.63M 3.55M Mar/2025